NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

Businesswire12/09 19:50

NovaBay Pharmaceuticals To Reconvene Special Meeting Of Stockholders To December 18, 2024; Initial Meeting Adjourned Due To Insufficient Votes To Reach The 50% Threshold Of Outstanding Common Shares Voting In Favor Of Proposal One And Two

Benzinga11/23 05:08

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of Its Avenova Brand

Businesswire11/15 21:00

Ascendiant Capital Maintains Buy on NovaBay Pharmaceuticals, Adjusts Price Target To $0.85 (1-35 Reverse Stock Split)

Benzinga11/12 01:44

NovaBay GAAP EPS of -$0.60 Misses by $0.30, Revenue of $2.44M Misses by $0.19M

Seeking Alpha11/08 13:01

ノヴァベイ ファーマシューティカルズ | 10-Q：Q3 2024 四半期報告書

SEC11/08 05:20